ANG Lifesciences India Ltd - 540694 - Disclosure And Intimation Of Non-Applicability Of SEBI Circular No SEBI/HO/DDHS/Clr/P /2018/744 Dated November 26, 2018 With Respect To Fund Raising By Issuance Of Debt Securities By Large Entities.
We hereby confirm that ANG Lifesciences India Limited is not falling under Large Corporate category as on 31st March, 2024 ANG Lifesciences India Ltd - 540694 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Please find & enclosed herewith certificate under Reg. 40(9) of SEBI LODR Reg. 2015 ANG Lifesciences India Ltd - 540694 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find & enclosed herewith certificate dated 15.04.2024 issued by Bigshare Services Pvt Ltd (RTA) for the quarter ended as at 31.03.2024 ANG Lifesciences India Ltd - 540694 - Compliance Certificate For The Year Ended 31.03.2024
Please find & enclosed herewith Compliance certificate under Reg 7(3) ofSEBI LODR, 2015 for the year ended 31.03.2024 ANG Lifesciences India Ltd - 540694 - Clarification On Price Movement
Sir/Madam, We hereby submit the clarification about Share price movement. ANG Lifesciences India Ltd - 540694 - Clarification sought from ANG Lifesciences India Ltd
The Exchange has sought clarification from ANG Lifesciences India Ltd on April 8, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. ANG Lifesciences India Ltd - 540694 - Closure of Trading Window
Closure of Trading window from 01st April 2024 till the end of 48 hrs. after the declaration of Audited Standalone and Consolidated Financial Result for the quarter and year ended on 31.03.2024 ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 & 47, please find enclosed herewith copies of Newspaper Advertisements of Unaudited Financial Results as on 31.12.2023. ANG Lifesciences India Ltd - 540694 - Disclosure Of Unaudited Financial Results For Quarter And Nine Months Ended 31.12.2023.
Please find enclosed the Unaudited Financial Results for quarter and nine months ended 31.12.2023. ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Outcome Of Board Meeting 14.02.2024.
Pursuant to Regulation 30 & 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors in its meeting held on Wednesday, 14th February, 2024 has considered and approved the Standalone & Consolidated Un-Audited Financial Results of the Company for the Quarter and Nine month ended on December 31, 2023 along with the Limited Review Report thereon issued by M/s Singh Bhupinder & Associates, Statutory Auditors of the Company.